Renovorx Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$0.99

+0.04 (+4.11%)

As of Feb 8, 2:21 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 9 90%

Hold 1 10%

Sell 0 0%

Price Target

Analyst Price Target +3,682.8% upside

Low Target $24.30

Average Target $37.45

High Target $44.03

Current Price $0.99

Current
$0.99

Target
$37.45

$24.30 $37.45 avg $44.03

Scenario Analysis

Bear Case

$24.30

2,354.5%

Low target

Base Case

$37.45

+3,682.8%

Avg target

Bull Case

$44.03

+4,347.5%

High target

Risk/Reward

1.8x

Balanced

Price in Context

52-Week High

$39.87

-97.5% from high

52-Week Low

$20.28

+-95.1% from low

Target vs 52W High

$37.45

-6.1% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	37	68%	$257.58	+15.3%
AMGN Amgen Inc	Hold	41	54%	$190.87	-50.3%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	77%	$438.34	-8.3%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.2%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-68.8%
INSM Insmed Inc	Strong Buy	27	93%	$143.40	-4.3%
BIIB Biogen Inc	Hold	42	48%	$91.45	-54.5%